Knight Therapeutics Inc KHTRF

Primary Symbol: T.GUD

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Aside from share price ... smells right for some bolt-ons

<< Previous

Bullboard Posts

Next >>

Comment by Snowballgrowthon Jan 15, 2023 2:49pm

120 Views

Post# 35224372

RE:Aside from share price ... smells right for some bolt-ons

For now we have no clue about a bolt-on acquisition or a catalyst for the next year. Unless the company shows significant growth and EBITDA we could be value trapped here for some time.

Again I don't see a catalyst in coming months.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China